Supply Chain Archives
06/04/2025
Engineering for Impact: A Conversation with Mike Dybicz on the HV3 and Safepak Systems
When it comes to cell and gene therapy (CGT) logistics, innovation is about more than improving efficiency, it’s about safeguarding a patient’s only chance at treatment. We sat down with Mike Dybicz, Senior Vice President & Chief Product Development Officer, to discuss how Cryoport Systems is reshaping the future of CGT logistics with innovative products such as Cryoport Express® Cryogenic HV3 Shipping System and Safepak® System 1800, designed specifically to reduce risk, increase reliability, and ultimately improve patient outcomes.
03/12/2025
Global Experts, Local Presence: Strengthening Europe’s Advanced Therapy Supply Chain
The development and commercialization of Advanced Therapy Medicinal Products (ATMPs) in Europe require a highly coordinated supply chain. From temperature-controlled logistics and biostorage to regulatory compliance, every stage of the ATMP lifecycle depends on precision, reliability, and risk mitigation
03/04/2025
How Our Recent Innovative Solutions Meet Today’s Supply Chain Challenges
When advanced therapy organizations place innovation at the center of their approach to solving supply chain challenges, they prioritize the most important person involved – the waiting patient. An innovative, patient-centric approach reframes obstacles to focus on solutions that can ensure the vitality and protection of sensitive materials throughout every stage and phase of the journey to the patient’s bedside.
02/12/2025
Ensuring Patient Impact in Advanced Therapy Logistics: A Conversation with Cryoport Systems’ Experts
The logistics behind advanced therapies aren’t just about moving shipments from point A to point B, they’re about protecting the integrity of life-saving treatments and ensuring that patients receive them without compromise. Following their discussion at Advanced Therapies Week 2025, we sat down with Aruna Mor, Chief Commercial Officer, and Mike Dybicz, Senior Vice President & Chief Product Development Officer, to dive deeper into how Cryoport Systems prioritizes patient impact at every step of the supply chain.
02/12/2025
Advancing Cell and Gene Therapy on International Childhood Cancer Day
Every year on February 15th, International Childhood Cancer Day (ICCD) serves as a global platform to raise awareness about childhood cancer, advocate for improved access to care, and highlight the need for continued research and innovation. Pediatric cancer remains one of the leading causes of death among children worldwide, with approximately 400,000 new cases diagnosed each year.
02/06/2025
The Patient Ferris Wheel: Centering the Patient in the CGT Supply Chain
In a recent interview at ATW, Cryoport Systems' leadership discussed how securing the future of medicine starts with minimizing risk and maximizing patient impact. Their conversation, The Patient Ferris Wheel – Centering the Patient in CGT Supply Chain, explored how Cryoport Systems is driving innovation in shipping systems designed specifically for advanced therapies.
02/04/2025
Advancing Patient Outcomes Through Integrated Supply Chain Solutions
The landscape of advanced therapies is consistently shifting, requiring a seamless, high-quality supply chain to ensure the safe and effective delivery of life-saving treatments. In a recent interview at Advanced Therapies Week, Cryoport Systems leaders shared insights into how their integrated approach is shaping the future of supply chain management for the biopharmaceutical industry.
01/30/2025
